Cancer Research Targets  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 7865, August 15, 2007. doi: 10.1158/0008-5472.CAN-07-0353
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebillard, A.
Right arrow Articles by Dimanche-Boitrel, M.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebillard, A.
Right arrow Articles by Dimanche-Boitrel, M.-T.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells

Amélie Rebillard1, Xavier Tekpli1, Olivier Meurette1, Odile Sergent2, Gwenaëlle LeMoigne-Muller1, Laurent Vernhet1, Morgane Gorria1, Martine Chevanne2, Markus Christmann3, Bernd Kaina3, Laurent Counillon4, Erich Gulbins5, Dominique Lagadic-Gossmann1 and Marie-Thérèse Dimanche-Boitrel1

1 Institut National de la Sante et de la Recherche Medicale, Unité Mixte de Recherche 620, Institut Fédératif de Recherche 140 Génétique Fonctionnelle Agronomie et Santé, and 2 Unité Propre de Recherche de l'Enseignement Supérieur Equipe d'Accueil 3891, Univ Rennes 1, Rennes, France; 3 Institute of Toxicology, Mainz, Germany; 4 Laboratory of Cellular and Molecular Physiology, University of Nice-Sophia Antipolis, Nice, France; and 5 Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany

Requests for reprints: Marie-Thérèse Dimanche-Boitrel, Institut National de la Sante et de la Recherche Medicale UMR620, Faculté de Pharmacie, 2 Av du Pr Léon Bernard, 35043 Rennes, France. Phone: 33-0-2-23-23-48-37; Fax: 33-0-2-23-23-47-94; E-mail: marie-therese.boitrel{at}rennes.inserm.fr.

We have previously shown that cisplatin triggers an early acid sphingomyelinase (aSMase)-dependent ceramide generation concomitantly with an increase in membrane fluidity and induces apoptosis in HT29 cells. The present study further explores the role and origin of membrane fluidification in cisplatin-induced apoptosis. The rapid increase in membrane fluidity following cisplatin treatment was inhibited by membrane-stabilizing agents such as cholesterol or monosialoganglioside-1. In HT29 cells, these compounds prevented the early aggregation of Fas death receptor and of membrane lipid rafts on cell surface and significantly inhibited cisplatin-induced apoptosis without altering drug intracellular uptake or cisplatin DNA adducts formation. Early after cisplatin treatment, Na+/H+ membrane exchanger-1 (NHE1) was inhibited leading to intracellular acidification, aSMase was activated, and ceramide was detected at the cell membrane. Treatment of HT29 cells with Staphylococcus aureus sphingomyelinase increased membrane fluidity. Moreover, pretreatment with cariporide, a specific inhibitor of NHE1, inhibited cisplatin-induced intracellular acidification, aSMase activation, ceramide membrane generation, membrane fluidification, and apoptosis. Finally, NHE1-expressing PS120 cells were more sensitive to cisplatin than NHE1-deficient PS120 cells. Altogether, these findings suggest that the apoptotic pathway triggered by cisplatin involves a very early NHE1-dependent intracellular acidification leading to aSMase activation and increase in membrane fluidity. These events are independent of cisplatin-induced DNA adducts formation. The membrane exchanger NHE1 may be another potential target of cisplatin, increasing cell sensitivity to this compound. [Cancer Res 2007;67(16):7865–74]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Podechard, E. Le Ferrec, A. Rebillard, O. Fardel, and V. Lecureur
NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons
Cardiovasc Res, May 1, 2009; 82(2): 361 - 370.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. N. Bose, L. Maurmann, R. J. Mishur, L. Yasui, S. Gupta, W. S. Grayburn, H. Hofstetter, and T. Salley
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells
PNAS, November 25, 2008; 105(47): 18314 - 18319.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. L. Smith and E. H. Schuchman
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases
FASEB J, October 1, 2008; 22(10): 3419 - 3431.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. R. Schelling and B. G. Abu Jawdeh
Regulation of cell survival by Na+/H+ exchanger-1
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F625 - F632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.